 | 4-[2-(Butylamino)-5-[4-[(4-methylpiperazin-1-yl)methyl]phenyl]pyrrolo[2,3-d]pyrimidin-7-yl]cyclohexan-1-ol | IC50 | 7.97 [1] |
 | Quercetin | IC50 | 5090.0 [1] |
 | Staurosporine | IC50 | 8.0 [1] |
 | Ellagic acid | IC50 | 510.0 [1] |
 | Palbociclib | IC50 | 5000.0 [1] |
 | Doramapimod | IC50 | 30000.0 [1] |
 | Norlichexanthone | IC50 | 33000.0 [1] |
 | CID 56649281 | IC50 | 4.95 [1] |
 | 3-(1H-Indol-3-yl)-4-(3,4,5-trimethoxyphenyl)pyrrole-2,5-dione | IC50 | 43000.0 [1] |
 | (12E,25E,28E)-5,16,21,32-Tetrabromo-4,20-dihydroxy-12,25-bis(hydroxyimino)-2,18-dioxa-10,27-diazapentacyclo[28.2.2.214,17.13,7.119,23]octatriaconta-1(32),3,5,7(38),14,16,19,21,23(35),28,30,33,36-tridecaene-11,26-dione | IC50 | 3200.0 [1] |
 | (1S,2S,3R,4R)-3-[[5-Chloro-2-[[(7S)-4-methoxy-7-morpholin-4-yl-6,7,8,9-tetrahydro-5H-benzo[7]annulen-3-yl]amino]pyrimidin-4-yl]amino]bicyclo[2.2.1]hept-5-ene-2-carboxamide | IC50 | 26.0 [1] |
 | 2,3,6,8-Tetrahydroxy-1-methylxanthone | IC50 | 15600.0 [1] |
 | Epicoccolide B | IC50 | 3770.0 [1] |
 | 4-[5-[4-[(4-Methyl-1,4-diazepan-1-yl)methyl]phenyl]-2-[[(2S)-pentan-2-yl]amino]pyrrolo[2,3-d]pyrimidin-7-yl]cyclohexan-1-ol | IC50 | 100.0 [1] |
 | 5-[6-(1-Methylpiperidin-4-yl)oxybenzimidazol-1-yl]-3-[(1R)-1-[2-(trifluoromethyl)phenyl]ethoxy]thiophene-2-carboxamide | IC50 | 840.0 [1] |
 | Astrogorgiadiol B | IC50 | 100000.0 [1] |
 | (1S,9R)-5,6,12,13,14-Pentahydroxy-4,11-dimethyl-16-oxo-8,17-dioxatetracyclo[7.7.1.02,7.010,15]heptadeca-2(7),3,5,10,12,14-hexaene-3-carbaldehyde | IC50 | 2510.0 [1] |
 | (1R,3As,4S,5R,7aR)-4-[2-(5-hydroxy-2-methylphenyl)ethyl]-7a-methyl-1-[(2R)-6-methyl-5-methylideneheptan-2-yl]-1,2,3,3a,4,5,6,7-octahydroinden-5-ol | IC50 | 100000.0 [1] |
 | Calicoferol B | IC50 | 100000.0 [1] |
 | (2Z)-3-[3-Bromo-5-[3-bromo-5-[(2Z)-3-[2-(3-bromo-4-hydroxyphenyl)ethylamino]-2-hydroxyimino-3-oxopropyl]-2-hydroxyphenyl]-4-hydroxyphenyl]-N-[2-(3-bromo-4-hydroxyphenyl)ethyl]-2-hydroxyiminopropanamide | IC50 | 1800.0 [1] |
 | GSK 461364 analogue I | IC50 | 2000.0 [1] |
 | 5-Propan-2-yl-7,8-dihydro-6H-indeno[1,2-b]indole-9,10-dione | IC50 | 35000.0 [1] |
 | 7-Chloro-3-oxo-8-(1,3-thiazol-5-ylmethylamino)-11,16-dioxa-2,4,19,21-tetrazatricyclo[15.3.1.05,10]henicosa-1(20),5,7,9,17(21),18-hexaene-18-carbonitrile | Ki | 1503.0 [1] |
 | Calicoferol E | IC50 | 100000.0 [1] |
 | 4-(1-Methylindol-3-yl)-3-(3,4,5-trimethoxyphenyl)-1,2-dihydropyrrol-5-one | IC50 | 4900.0 [1] |
 | 1-[5-Tert-butyl-3-[4-[2-(dimethylamino)ethyl]-5-oxo-1,4-diazepane-1-carbonyl]thiophen-2-yl]-3-(2,3-dichlorophenyl)urea | IC50 | 30000.0 [1] |
 | 6-(2,4-Difluorophenyl)sulfonyl-2-(1H-indol-5-ylamino)-8-methylpyrido[2,3-d]pyrimidin-7-one | IC50 | 10000.0 [1] |
 | 2-Anilino-7-[(1S)-4-hydroxy-2,3-dihydro-1H-inden-1-yl]-5,5-dimethylpyrrolo[2,3-d]pyrimidin-6-one | IC50 | 5.0 [1] |
 | (8S,16S)-3,16-Dihydroxy-9,10-seco-1,3,5(10)-cholestatrien-9-one | IC50 | 100000.0 [1] |
 | Calicoferol A | IC50 | 100000.0 [1] |
 | (1R,3As,4S,7aR)-4-[2-(5-hydroxy-2-methylphenyl)ethyl]-7a-methyl-1-[(2R)-6-methyl-5-methylideneheptan-2-yl]-2,3,3a,4,6,7-hexahydro-1H-inden-5-one | IC50 | 100000.0 [1] |
 | Methyl 3-[[(1R,2S,4aR,8aS)-1,2,4a,5-tetramethyl-2,3,4,7,8,8a-hexahydronaphthalen-1-yl]methyl]-4,5-dihydroxybenzoate | IC50 | 29400.0 [1] |
 | 5-(1H-Indol-3-yl)-3-(3,4,5-trimethoxyphenyl)-1H-pyrazin-2-one | IC50 | 100000.0 [1] |
 | 3-[2-(4-Amino-1-ethylpyrazolo[3,4-d]pyrimidin-3-yl)ethynyl]-4-methyl-N-[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]benzamide | IC50 | 10000.0 [1] |
 | 4-[(4-Aminocyclohexyl)amino]-3-(1h-Benzimidazol-2-Yl)-1h-Pyridin-2-One | IC50 | 2.0 [1] |
 | Nintedanib impurity E | Ki | 1.7 [1] |
 | Melk-IN-1 | Ki | 11.0 [1] |
 | 2-Hydroxy-3-[N-[4-[methyl-[2-(4-methylpiperazin-1-yl)acetyl]amino]phenyl]-C-phenylcarbonimidoyl]-1H-indole-5-carboxylic acid | Ki | 8.6 [1] |
 | 3-(1H-Indol-3-yl)-4-(4-methoxyphenyl)-1,5-dihydro-2H-pyrrole-2-one | IC50 | 2000.0 [1] |
 | 3-(N-Methyl-1H-indol-3-yl)-4-(4-methoxyphenyl)-1,5-dihydro-2H-pyrrole-2-one | IC50 | 3600.0 [1] |
 | 4-(1H-Indol-3-yl)-3-(3,4,5-trimethoxyphenyl)-1,2-dihydropyrrol-5-one | IC50 | 1800.0 [1] |
 | 3-[1-(2,3-Dihydroxypropyl)indol-3-yl]-4-(3,4,5-trimethoxyphenyl)-1,2-dihydropyrrol-5-one | IC50 | 34000.0 [1] |
 | 3-(12,14-Dioxo-10,13,16-triazahexacyclo[14.6.1.02,10.04,9.011,15.019,23]tricosa-1(22),2,4,6,8,11(15),17,19(23),20-nonaen-13-yl)propyl N'-methylcarbamimidothioate | IC50 | 9700.0 [1] |
 | (1R,3As,4S,5S,7aR)-4-[2-(5-hydroxy-2-methylphenyl)ethyl]-7a-methyl-1-[(E,2R)-6-methylhept-3-en-2-yl]-1,2,3,3a,4,5,6,7-octahydroinden-5-ol | IC50 | 100000.0 [1] |
 | (2E)-3-[3-Bromo-5-[3-bromo-5-[(2E)-3-[2-[3-bromo-4-[3-bromo-5-[(2E)-3-[2-(3-bromo-4-hydroxyphenyl)ethylamino]-2-hydroxyimino-3-oxopropyl]-2-hydroxyphenoxy]phenyl]ethylamino]-2-hydroxyimino-3-oxopropyl]-2-hydroxyphenyl]-4-hydroxyphenyl]-N-[2-(3-bromo-4-hydroxyphenyl)ethyl]-2-hydroxyiminopropanamide | IC50 | 1700.0 [1] |
 | 5-Propan-2-yl-7,8-dihydroindeno[1,2-b]indole-6,9,10-trione | IC50 | 570.0 [1] |
 | 5,6,7-Trihydroxy-3-methoxy-4-methyl-3H-2-benzofuran-1-one | IC50 | 29800.0 [1] |
 | 3-[[(1R,2S,4Ar,8aS)-1,2,4a,5-tetramethyl-2,3,4,7,8,8a-hexahydronaphthalen-1-yl]methyl]-4-hydroxy-5-(3-methylbutylamino)cyclohexa-3,5-diene-1,2-dione | IC50 | 100000.0 [1] |
 | CID 76324771 | IC50 | 30000.0 [1] |
 | 4-Methyl-5,6,7-trihydroxy-1,3-dihydroisobenzofuran-1-one | IC50 | 10000.0 [1] |
 | 7-[[(1R,2S,4Ar,8aS)-1,2,4a,5-tetramethyl-2,3,4,7,8,8a-hexahydronaphthalen-1-yl]methyl]-5-methoxy-2-methyl-1,3-benzoxazol-6-ol | IC50 | 100000.0 [1] |
Calculator
